Join
Live feed
·
PRReleasevia Quantisnow
Niagen Bioscience Inc. logo
Evotec SE logo

Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168

ByQuantisnow·Wall Street's wire, on your screen.
NAGE· Niagen Bioscience Inc.EVO· Evotec SE
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAGE (Niagen Bioscience Inc.), EVO (Evotec SE) and more on Quantisnow.